Review
Sep 2026
Melatonin and Diabetic Nephropathy: From Mechanistic Pathways to Translational Opportunities in Clinical Management.
INTRODUCTION/OBJECTIVE Diabetic Nephropathy (DN) remains a leading cause of end-stage renal disease worldwide, characterized by a complex interplay of oxidative stress, chronic inflammation, and circadian rhythm disruption. Despite standard-of-care treatments like RAS inhibitors and newer agents like SGLT2 inhibitors a...
Mohammad Saleh Chapani, Kosar Ostadmohammadi, Mohammad Moulaei-Arani et al.
· Current Medicinal Chemistry · 0 citations